Skip to main content
SpringerLink
Log in

Filgrastim: an important advance in the treatment of severe chronic neutropenia

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Frampton JE, Lee CR, Faulds D. Filgrastim: a review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994 Nov; 48(5): 731–60

    Article  PubMed  CAS  Google Scholar 

  2. Boxer LA, Hutchinson R, Emerson S. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia. Clin Immunol Immunopathol 1992 Jan; 62(1): S39–S46

    Article  PubMed  CAS  Google Scholar 

  3. Wilson JD, et al., editors. Harrison’s principles of internal medicine, 12th ed. New York: McGraw-Hill, 1991: 361

    Google Scholar 

  4. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993 May 15; 81: 2496–502

    PubMed  CAS  Google Scholar 

  5. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994 Dec; 88: 723–30

    Article  PubMed  CAS  Google Scholar 

  6. Fazio MT, Glaspy JA. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nurs Forum 1991; 28(8): 1411–4

    Google Scholar 

  7. Jones EA, Bolyard AA, Dale DC. Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. JAMA 1993 Sep 1; 270: 1132–3

    Article  PubMed  CAS  Google Scholar 

  8. Grant SM, Heel RC. Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): a review of its pharmacological properties and prospective role in the management of myelosuppression. Drugs 1992; 43: 516–60

    Article  PubMed  CAS  Google Scholar 

  9. Welte K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990; 75: 1056–63

    PubMed  CAS  Google Scholar 

  10. Freund MRF, Luft S, Schöber C, et al. Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet 1990; 336: 313

    Article  PubMed  CAS  Google Scholar 

  11. Mori PG, Pasino M, Dufour C, et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia. Blood 1994 Nov 1; 84: 3244–5

    PubMed  CAS  Google Scholar 

  12. Kaczmarski RS, Pozniak A, Lakhani A, et al. A pilot study of low-dose recombinant human granulocyte-macrophage colony stimulating factor in chronic neutropenia. Br J Haematol 1993 Jun; 84: 338–40

    Article  PubMed  CAS  Google Scholar 

  13. Woermann UJ, Schenk R, Zimmermann A, et al. Increased bone metabolism in a patient undergoing long-term rhG-CSF treatment for idiopathic acquired neutropenia. Ann Hematol 1993 May; 66: 267–8

    Article  PubMed  CAS  Google Scholar 

  14. Imashuku S, Hibi S, Kataoka-Morimoto Y, et al. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol 1995 Jan; 89: 188–90

    Article  PubMed  CAS  Google Scholar 

  15. Weinblatt ME, Scimeca P, James-Herry A, et al. Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. J Pediatr 1995 Feb; 126: 263–5

    Article  PubMed  CAS  Google Scholar 

  16. Jayabose S, Tugal O, Sandoval C, et al. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen. Am J Pediatr Hematol Oncol 1994 Nov; 16: 338–40

    PubMed  CAS  Google Scholar 

  17. Kaczmarski RS, Mufti GJ. Low-dose filgrastim therapy for chronic neutropenia [letter]. N Engl J Med 1993 Oct 21; 329: 1280–1

    Article  PubMed  CAS  Google Scholar 

  18. British National Formulary No. 29. London: The Pharmaceutical Press, 1995; 357

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Filgrastim: an important advance in the treatment of severe chronic neutropenia. Drugs Ther. Perspect 5, 5–8 (1995). https://doi.org/10.2165/00042310-199505110-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505110-00002

Keywords

Search

Navigation